Statements ( 22 record(s) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024
Statement MD&A Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024 2024 Reviewed Consolidated Q2 30/06/2024 2024 Reviewed Company Q2 30/06
No. KorThor. 3/2551 Re: Additional Determination of Type of Juristic Person Classified as Institutional Investors _____________ By virtue of Clause 3 and Clause 9 of the Derivatives Act B.E.2546 (2003
and Investment Consultant dated January 18, 2012; classified as prohibited characteristics of personnel in capital market according to Clause 6(1) and (2) of the of the Notification of Capital Market
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
MDA_EN_1Q20 Management Discussion and Analysis For the 1 st Quarter 2020 ended May 31, 2020 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated
MDAE_2Q18 Management Discussion and Analysis for the 2 nd Quarter 2018 ended August 31, 2018 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated
consolidated reviewed the 3 rd quarter financial statements as of November 30, 2018 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as
Management Discussion and Analysis For the 1st Quarter 2021 ended May 31, 2021 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated reviewed the